View in EDS HTML Full Text PDF Full Text

Neutrophil‐to‐eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti‐PD‐1 therapy.

Saved in:
Bibliographic Details
Title: Neutrophil‐to‐eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti‐PD‐1 therapy.
Authors: Pozorski, Vincent1 (AUTHOR), Park, Yeonhee2 (AUTHOR), Mohamoud, Yusuf1 (AUTHOR), Tesfamichael, Dahlia1 (AUTHOR), Emamekhoo, Hamid3,4 (AUTHOR), Birbrair, Alexander1,5 (AUTHOR), Albertini, Mark R.3,4,5,6 (AUTHOR), Ma, Vincent T.3,4,5 (AUTHOR) vtma@medicine.wisc.edu
Source: Pigment Cell & Melanoma Research. Nov2023, Vol. 36 Issue 6, p501-511. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17551471
DOI:10.1111/pcmr.13109